#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-3	The	_
1-2	4-10	neural	_
1-3	11-21	correlates	_
1-4	22-24	of	_
1-5	25-32	priming	_
1-6	33-40	emotion	_
1-7	41-44	and	_
1-8	45-51	reward	_
1-9	52-59	systems	_
1-10	60-63	for	_
1-11	64-72	conflict	_
1-12	73-83	processing	_
1-13	84-86	in	_
1-14	87-97	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-15	98-107	Emotional	_
1-16	108-121	dysregulation	_
1-17	122-124	in	_
1-18	125-135	alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-19	136-137	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-20	138-141	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-21	142-143	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-22	144-147	may	_
1-23	148-154	result	_
1-24	155-159	from	_
1-25	160-169	disturbed	_
1-26	170-180	inhibitory	_
1-27	181-191	mechanisms	_
1-28	192-193	.	_

2-1	194-196	We	_
2-2	197-206	therefore	_
2-3	207-213	tested	_
2-4	214-221	emotion	_
2-5	222-225	and	_
2-6	226-233	alcohol	_
2-7	234-237	cue	_
2-8	238-248	reactivity	_
2-9	249-252	and	_
2-10	253-263	inhibitory	_
2-11	264-273	processes	_
2-12	274-279	using	_
2-13	280-288	negative	_
2-14	289-296	priming	_
2-15	297-298	.	_

3-1	299-301	To	_
3-2	302-306	test	_
3-3	307-310	the	_
3-4	311-317	neural	_
3-5	318-328	correlates	_
3-6	329-331	of	_
3-7	332-335	cue	_
3-8	336-346	reactivity	_
3-9	347-350	and	_
3-10	351-359	negative	_
3-11	360-367	priming	_
3-12	368-369	,	_
3-13	370-372	26	_
3-14	373-376	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
3-15	377-380	and	_
3-16	381-383	26	_
3-17	384-395	age-matched	_
3-18	396-404	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-19	405-414	underwent	_
3-20	415-425	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-21	426-429	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-22	430-440	performing	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-23	441-442	a	_
3-24	443-449	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
3-25	450-455	color	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
3-26	456-471	match-to-sample	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
3-27	472-476	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
3-28	477-478	.	_

4-1	479-481	In	_
4-2	482-485	cue	_
4-3	486-496	reactivity	_
4-4	497-503	trials	_
4-5	504-505	,	_
4-6	506-521	task-irrelevant	_
4-7	522-529	emotion	_
4-8	530-533	and	_
4-9	534-549	alcohol-related	_
4-10	550-558	pictures	_
4-11	559-563	were	_
4-12	564-576	interspersed	_
4-13	577-584	between	_
4-14	585-590	color	_
4-15	591-598	samples	_
4-16	599-602	and	_
4-17	603-608	color	_
4-18	609-614	words	_
4-19	615-616	.	_

5-1	617-619	In	_
5-2	620-628	negative	_
5-3	629-636	priming	_
5-4	637-643	trials	_
5-5	644-645	,	_
5-6	646-654	pictures	_
5-7	655-661	primed	_
5-8	662-665	the	_
5-9	666-674	semantic	_
5-10	675-682	content	_
5-11	683-685	of	_
5-12	686-688	an	_
5-13	689-696	alcohol	_
5-14	697-699	or	_
5-15	700-707	emotion	_
5-16	708-714	Stroop	_
5-17	715-719	word	_
5-18	720-721	.	_

6-1	722-734	Behaviorally	_
6-2	735-736	,	_
6-3	737-741	both	_
6-4	742-748	groups	_
6-5	749-755	showed	_
6-6	756-764	response	_
6-7	765-777	facilitation	_
6-8	778-780	to	_
6-9	781-788	picture	_
6-10	789-792	cue	_
6-11	793-799	trials	_
6-12	800-803	and	_
6-13	804-812	response	_
6-14	813-823	inhibition	_
6-15	824-826	to	_
6-16	827-833	primed	_
6-17	834-840	trials	_
6-18	841-842	.	_

7-1	843-846	For	_
7-2	847-850	cue	_
7-3	851-861	reactivity	_
7-4	862-864	to	_
7-5	865-872	emotion	_
7-6	873-876	and	_
7-7	877-884	alcohol	_
7-8	885-893	pictures	_
7-9	894-895	,	_
7-10	896-899	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
7-11	900-906	showed	_
7-12	907-922	midbrain-limbic	_
7-13	923-933	activation	_
7-14	934-935	.	_

8-1	936-938	By	_
8-2	939-947	contrast	_
8-3	948-949	,	_
8-4	950-958	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
8-5	959-968	activated	_
8-6	969-983	frontoparietal	_
8-7	984-993	executive	_
8-8	994-1001	control	_
8-9	1002-1009	regions	_
8-10	1010-1011	.	_

9-1	1012-1019	Greater	_
9-2	1020-1040	midbrain-hippocampal	_
9-3	1041-1051	activation	_
9-4	1052-1054	in	_
9-5	1055-1058	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
9-6	1059-1069	correlated	_
9-7	1070-1074	with	_
9-8	1075-1081	higher	_
9-9	1082-1089	amounts	_
9-10	1090-1092	of	_
9-11	1093-1101	lifetime	_
9-12	1102-1109	alcohol	_
9-13	1110-1121	consumption	_
9-14	1122-1125	and	_
9-15	1126-1132	higher	_
9-16	1133-1140	anxiety	_
9-17	1141-1142	.	_

10-1	1143-1147	With	_
10-2	1148-1156	negative	_
10-3	1157-1164	priming	_
10-4	1165-1166	,	_
10-5	1167-1170	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
10-6	1171-1180	exhibited	_
10-7	1181-1188	frontal	_
10-8	1189-1197	cortical	_
10-9	1198-1201	but	_
10-10	1202-1205	not	_
10-11	1206-1226	midbrain-hippocampal	_
10-12	1227-1237	activation	_
10-13	1238-1239	,	_
10-14	1240-1247	similar	_
10-15	1248-1250	to	_
10-16	1251-1254	the	_
10-17	1255-1262	pattern	_
10-18	1263-1271	observed	_
10-19	1272-1274	in	_
10-20	1275-1283	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
10-21	1284-1285	.	_

11-1	1286-1292	Higher	_
11-2	1293-1300	frontal	_
11-3	1301-1311	activation	_
11-4	1312-1314	to	_
11-5	1315-1330	alcohol-priming	_
11-6	1331-1341	correlated	_
11-7	1342-1346	with	_
11-8	1347-1351	less	_
11-9	1352-1359	craving	_
11-10	1360-1363	and	_
11-11	1364-1366	to	_
11-12	1367-1382	emotion-priming	_
11-13	1383-1387	with	_
11-14	1388-1393	fewer	_
11-15	1394-1404	depressive	_
11-16	1405-1413	symptoms	_
11-17	1414-1415	.	_

12-1	1416-1419	The	_
12-2	1420-1428	findings	_
12-3	1429-1436	suggest	_
12-4	1437-1441	that	_
12-5	1442-1457	neurofunctional	_
12-6	1458-1465	systems	_
12-7	1466-1468	in	_
12-8	1469-1472	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
12-9	1473-1476	can	_
12-10	1477-1479	be	_
12-11	1480-1486	primed	_
12-12	1487-1489	to	_
12-13	1490-1494	deal	_
12-14	1495-1499	with	_
12-15	1500-1508	upcoming	_
12-16	1509-1517	emotion-	_
12-17	1518-1521	and	_
12-18	1522-1537	alcohol-related	_
12-19	1538-1546	conflict	_
12-20	1547-1550	and	_
12-21	1551-1554	can	_
12-22	1555-1563	overcome	_
12-23	1564-1567	the	_
12-24	1568-1577	prepotent	_
12-25	1578-1593	midbrain-limbic	_
12-26	1594-1597	cue	_
12-27	1598-1608	reactivity	_
12-28	1609-1617	response	_
12-29	1618-1619	.	_

13-1	1620-1627	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-2	1628-1631	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-3	1632-1641	materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-4	1642-1654	Participants	_
13-5	1655-1660	Study	_
13-6	1661-1673	participants	_
13-7	1674-1678	were	_
13-8	1679-1681	26	_
13-9	1682-1691	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-10	1692-1699	chronic	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-11	1700-1717	alcohol-dependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-12	1718-1726	patients	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-13	1727-1728	(	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-14	1729-1732	ALC	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-15	1733-1734	)	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
13-16	1735-1738	and	_
13-17	1739-1741	26	_
13-18	1742-1745	age	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-19	1746-1749	and	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-20	1750-1761	sex-matched	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-21	1762-1770	controls	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-22	1771-1772	(	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-23	1773-1776	CTL	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-24	1777-1778	)	http://maven.renci.org/NeuroBridge/neurobridge#RandomizedControlTrial
13-25	1779-1780	.	_

14-1	1781-1791	Functional	_
14-2	1792-1804	neuroimaging	_
14-3	1805-1809	data	_
14-4	1810-1814	from	_
14-5	1815-1826	overlapping	_
14-6	1827-1834	samples	_
14-7	1835-1839	were	_
14-8	1840-1849	published	_
14-9	1850-1853	for	_
14-10	1854-1863	different	_
14-11	1864-1869	tasks	_
14-12	1870-1873	and	_
14-13	1874-1887	resting-state	_
14-14	1888-1889	.	_

15-1	1890-1894	Here	_
15-2	1895-1896	,	_
15-3	1897-1899	we	_
15-4	1900-1907	focused	_
15-5	1908-1910	on	_
15-6	1911-1918	priming	_
15-7	1919-1925	neural	_
15-8	1926-1933	systems	_
15-9	1934-1937	for	_
15-10	1938-1945	emotion	_
15-11	1946-1949	and	_
15-12	1950-1965	alcohol-related	_
15-13	1966-1974	conflict	_
15-14	1975-1985	processing	_
15-15	1986-1991	using	_
15-16	1992-1993	a	_
15-17	1994-1999	novel	_
15-18	2000-2001	‘	_
15-19	2002-2009	Priming	_
15-20	2010-2017	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
15-21	2018-2021	and	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
15-22	2022-2029	Emotion	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
15-23	2030-2031	’	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
15-24	2032-2038	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
15-25	2039-2054	Match-to-Sample	_
15-26	2055-2063	paradigm	_
15-27	2064-2065	.	_

16-1	2066-2069	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
16-2	2070-2082	participants	_
16-3	2083-2087	were	_
16-4	2088-2097	recruited	_
16-5	2098-2102	from	_
16-6	2103-2108	local	_
16-7	2109-2123	rehabilitation	_
16-8	2124-2132	programs	_
16-9	2133-2136	and	_
16-10	2137-2146	self-help	_
16-11	2147-2153	groups	_
16-12	2154-2155	;	_
16-13	2156-2164	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-14	2165-2169	were	_
16-15	2170-2180	volunteers	_
16-16	2181-2185	from	_
16-17	2186-2189	the	_
16-18	2190-2195	local	_
16-19	2196-2205	community	_
16-20	2206-2215	recruited	_
16-21	2216-2223	through	_
16-22	2224-2230	flyers	_
16-23	2231-2232	,	_
16-24	2233-2246	announcements	_
16-25	2247-2248	,	_
16-26	2249-2251	or	_
16-27	2252-2256	word	_
16-28	2257-2259	of	_
16-29	2260-2265	mouth	_
16-30	2266-2267	.	_

17-1	2268-2271	All	_
17-2	2272-2280	subjects	_
17-3	2281-2290	underwent	_
17-4	2291-2292	a	_
17-5	2293-2303	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-6	2304-2312	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-7	2313-2322	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-8	2323-2326	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-9	2327-2333	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-10	2334-2335	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-11	2336-2340	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-12	2341-2342	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-13	2343-2345	to	_
17-14	2346-2355	determine	_
17-15	2356-2359	the	_
17-16	2360-2369	diagnosis	_
17-17	2370-2372	of	_
17-18	2373-2380	alcohol	_
17-19	2381-2391	dependence	_
17-20	2392-2394	by	_
17-21	2395-2404	consensus	_
17-22	2405-2407	of	_
17-23	2408-2410	at	_
17-24	2411-2416	least	_
17-25	2417-2420	two	_
17-26	2421-2431	calibrated	_
17-27	2432-2444	interviewers	_
17-28	2445-2446	(	_
17-29	2447-2455	clinical	_
17-30	2456-2464	research	_
17-31	2465-2478	psychologists	_
17-32	2479-2480	,	_
17-33	2481-2489	research	_
17-34	2490-2495	nurse	_
17-35	2496-2497	)	_
17-36	2498-2501	and	_
17-37	2502-2504	to	_
17-38	2505-2517	characterize	_
17-39	2518-2529	psychiatric	_
17-40	2530-2537	history	_
17-41	2538-2539	.	_

18-1	2540-2547	History	_
18-2	2548-2550	of	_
18-3	2551-2564	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-4	2565-2568	and	_
18-5	2569-2576	bipolar	_
18-6	2577-2586	disorders	_
18-7	2587-2591	were	_
18-8	2592-2602	exclusions	_
18-9	2603-2604	;	_
18-10	2605-2608	the	_
18-11	2609-2616	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-12	2617-2624	control	_
18-13	2625-2630	group	_
18-14	2631-2634	had	_
18-15	2635-2637	no	_
18-16	2638-2645	current	_
18-17	2646-2648	or	_
18-18	2649-2653	past	_
18-19	2654-2658	Axis	_
18-20	2659-2660	1	_
18-21	2661-2672	psychiatric	_
18-22	2673-2681	disorder	_
18-23	2682-2683	.	_

19-1	2684-2691	Current	_
19-2	2692-2695	use	_
19-3	2696-2698	of	_
19-4	2699-2711	psychoactive	_
19-5	2712-2723	medications	_
19-6	2724-2725	;	_
19-7	2726-2733	history	_
19-8	2734-2736	of	_
19-9	2737-2742	major	_
19-10	2743-2755	neurological	_
19-11	2756-2758	or	_
19-12	2759-2766	medical	_
19-13	2767-2775	disorder	_
19-14	2776-2777	,	_
19-15	2778-2782	head	_
19-16	2783-2789	trauma	_
19-17	2790-2794	with	_
19-18	2795-2799	loss	_
19-19	2800-2802	of	_
19-20	2803-2816	consciousness	_
19-21	2817-2818	(	_
19-22	2819-2820	>	_
19-23	2821-2823	30	_
19-24	2824-2827	min	_
19-25	2828-2829	)	_
19-26	2830-2831	,	_
19-27	2832-2835	MRI	_
19-28	2836-2853	contraindications	_
19-29	2854-2855	(	_
19-30	2856-2860	e.g.	_
19-31	2861-2862	,	_
19-32	2863-2874	irremovable	_
19-33	2875-2880	metal	_
19-34	2881-2882	)	_
19-35	2883-2884	,	_
19-36	2885-2900	color-blindness	_
19-37	2901-2902	,	_
19-38	2903-2906	and	_
19-39	2907-2922	non-correctable	_
19-40	2923-2929	vision	_
19-41	2930-2934	were	_
19-42	2935-2939	also	_
19-43	2940-2950	exclusions	_
19-44	2951-2952	.	_

20-1	2953-2961	Although	_
20-2	2962-2965	ALC	_
20-3	2966-2970	were	_
20-4	2971-2974	not	_
20-5	2975-2986	necessarily	_
20-6	2987-2994	seeking	_
20-7	2995-3004	treatment	_
20-8	3005-3007	at	_
20-9	3008-3011	the	_
20-10	3012-3016	time	_
20-11	3017-3019	of	_
20-12	3020-3023	the	_
20-13	3024-3029	study	_
20-14	3030-3031	,	_
20-15	3032-3036	they	_
20-16	3037-3040	had	_
20-17	3041-3047	sought	_
20-18	3048-3057	treatment	_
20-19	3058-3060	at	_
20-20	3061-3065	some	_
20-21	3066-3070	time	_
20-22	3071-3077	during	_
20-23	3078-3081	the	_
20-24	3082-3088	course	_
20-25	3089-3091	of	_
20-26	3092-3097	their	_
20-27	3098-3105	disease	_
20-28	3106-3107	.	_

21-1	3108-3110	Of	_
21-2	3111-3114	the	_
21-3	3115-3117	26	_
21-4	3118-3121	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
21-5	3122-3123	,	_
21-6	3124-3126	25	_
21-7	3127-3130	met	_
21-8	3131-3137	DSM-IV	_
21-9	3138-3146	criteria	_
21-10	3147-3150	for	_
21-11	3151-3158	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
21-12	3159-3169	dependence	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
21-13	3170-3173	and	_
21-14	3174-3177	one	_
21-15	3178-3181	for	_
21-16	3182-3189	alcohol	_
21-17	3190-3195	abuse	http://maven.renci.org/NeuroBridge/neurobridge#BarbiturateAbuse
21-18	3196-3197	(	_
21-19	3198-3201	who	_
21-20	3202-3205	was	_
21-21	3206-3209	not	_
21-22	3210-3212	an	_
21-23	3213-3220	outlier	_
21-24	3221-3225	from	_
21-25	3226-3229	the	_
21-26	3230-3233	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
21-27	3234-3239	group	_
21-28	3240-3243	and	_
21-29	3244-3250	within	_
21-30	3251-3254	the	_
21-31	3255-3268	distributions	_
21-32	3269-3272	for	_
21-33	3273-3281	lifetime	_
21-34	3282-3289	alcohol	_
21-35	3290-3301	consumption	_
21-36	3302-3305	and	_
21-37	3306-3311	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
21-38	3312-3318	scores	_
21-39	3319-3320	)	_
21-40	3321-3322	;	_
21-41	3323-3325	24	_
21-42	3326-3330	were	_
21-43	3331-3333	in	_
21-44	3334-3339	early	_
21-45	3340-3349	remission	_
21-46	3350-3351	(	_
21-47	3352-3355	met	_
21-48	3356-3363	alcohol	_
21-49	3364-3374	dependence	_
21-50	3375-3383	criteria	_
21-51	3384-3387	for	_
21-52	3388-3390	≥3	_
21-53	3391-3397	months	_
21-54	3398-3401	and	_
21-55	3402-3403	<	_
21-56	3404-3406	12	_
21-57	3407-3413	months	_
21-58	3414-3415	)	_
21-59	3416-3417	;	_
21-60	3418-3421	one	_
21-61	3422-3425	was	_
21-62	3426-3428	in	_
21-63	3429-3438	sustained	_
21-64	3439-3448	remission	_
21-65	3449-3450	(	_
21-66	3451-3452	>	_
21-67	3453-3455	12	_
21-68	3456-3462	months	_
21-69	3463-3464	)	_
21-70	3465-3467	by	_
21-71	3468-3470	10	_
21-72	3471-3475	days	_
21-73	3476-3477	,	_
21-74	3478-3482	i.e.	_
21-75	3483-3484	,	_
21-76	3485-3488	had	_
21-77	3489-3493	last	_
21-78	3494-3497	met	_
21-79	3498-3505	alcohol	_
21-80	3506-3516	dependence	_
21-81	3517-3525	criteria	_
21-82	3526-3529	375	_
21-83	3530-3534	days	_
21-84	3535-3538	ago	_
21-85	3539-3540	.	_

22-1	3541-3551	Additional	_
22-2	3552-3560	clinical	_
22-3	3561-3567	scales	_
22-4	3568-3572	were	_
22-5	3573-3585	administered	_
22-6	3586-3588	to	_
22-7	3589-3597	quantify	_
22-8	3598-3608	alcoholism	_
22-9	3609-3617	severity	_
22-10	3618-3619	(	_
22-11	3620-3623	the	_
22-12	3624-3631	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-13	3632-3635	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-14	3636-3645	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-15	3646-3660	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-16	3661-3665	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-17	3666-3667	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-18	3668-3673	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-19	3674-3675	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
22-20	3676-3677	)	_
22-21	3678-3679	,	_
22-22	3680-3690	subjective	_
22-23	3691-3698	craving	_
22-24	3699-3706	shortly	_
22-25	3707-3713	before	_
22-26	3714-3718	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-27	3719-3730	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-28	3731-3732	(	_
22-29	3733-3738	Short	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-30	3739-3743	Item	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-31	3744-3749	Scale	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-32	3750-3757	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-33	3758-3765	Craving	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-34	3766-3787	Questionnaire-Revised	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-35	3788-3789	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-36	3790-3795	ACQ-R	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-37	3796-3797	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
22-38	3798-3799	)	_
22-39	3800-3801	,	_
22-40	3802-3805	and	_
22-41	3806-3815	emotional	_
22-42	3816-3821	state	_
22-43	3822-3823	(	_
22-44	3824-3835	State-Trait	_
22-45	3836-3843	Anxiety	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
22-46	3844-3853	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
22-47	3854-3855	(	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
22-48	3856-3860	STAI	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
22-49	3861-3862	)	_
22-50	3863-3864	,	_
22-51	3865-3869	Beck	_
22-52	3870-3880	Depression	_
22-53	3881-3890	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
22-54	3891-3892	(	_
22-55	3893-3899	BDI-II	_
22-56	3900-3901	)	_
22-57	3902-3903	)	_
22-58	3904-3905	.	_

23-1	3906-3910	Here	_
23-2	3911-3912	,	_
23-3	3913-3923	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
23-4	3924-3928	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
23-5	3929-3935	higher	_
23-6	3936-3943	anxiety	_
23-7	3944-3945	(	_
23-8	3946-3952	STAI-S	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
23-9	3953-3959	scores	_
23-10	3960-3961	)	_
23-11	3962-3966	also	_
23-12	3967-3975	reported	_
23-13	3976-3982	higher	_
23-14	3983-3990	alcohol	_
23-15	3991-3998	craving	_
23-16	3999-4000	(	_
23-17	4001-4006	ACQ-R	_
23-18	4007-4013	scores	_
23-19	4014-4015	)	_
23-20	4016-4017	(	_
23-21	4018-4021	ALC	_
23-22	4022-4023	:	_
23-23	4024-4027	Rho	_
23-24	4028-4029	=	_
23-25	4030-4033	.47	_
23-26	4034-4035	,	_
23-27	4036-4037	p	_
23-28	4038-4039	=	_
23-29	4040-4045	0.009	_
23-30	4046-4047	;	_
23-31	4048-4051	CTL	_
23-32	4052-4053	:	_
23-33	4054-4057	Rho	_
23-34	4058-4059	=	_
23-35	4060-4063	.02	_
23-36	4064-4065	,	_
23-37	4066-4068	ns	_
23-38	4069-4070	)	_
23-39	4071-4072	.	_

24-1	4073-4077	None	_
24-2	4078-4080	of	_
24-3	4081-4084	the	_
24-4	4085-4093	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
24-5	4094-4097	and	_
24-6	4098-4100	46	_
24-7	4101-4102	%	_
24-8	4103-4105	of	_
24-9	4106-4109	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
24-10	4110-4113	met	_
24-11	4114-4120	DSM-IV	_
24-12	4121-4129	criteria	_
24-13	4130-4133	for	_
24-14	4134-4138	past	_
24-15	4139-4143	drug	_
24-16	4144-4154	dependence	_
24-17	4155-4159	with	_
24-18	4160-4167	cocaine	_
24-19	4168-4173	being	_
24-20	4174-4178	used	_
24-21	4179-4183	most	_
24-22	4184-4189	often	_
24-23	4190-4192	by	_
24-24	4193-4195	35	_
24-25	4196-4197	%	_
24-26	4198-4199	(	_
24-27	4200-4201	n	_
24-28	4202-4203	=	_
24-29	4204-4205	9	_
24-30	4206-4207	)	_
24-31	4208-4209	,	_
24-32	4210-4222	amphetamines	_
24-33	4223-4225	by	_
24-34	4226-4228	12	_
24-35	4229-4230	%	_
24-36	4231-4232	(	_
24-37	4233-4234	n	_
24-38	4235-4236	=	_
24-39	4237-4238	3	_
24-40	4239-4240	)	_
24-41	4241-4242	,	_
24-42	4243-4246	and	_
24-43	4247-4254	opioids	_
24-44	4255-4257	by	_
24-45	4258-4260	12	_
24-46	4261-4262	%	_
24-47	4263-4264	(	_
24-48	4265-4266	n	_
24-49	4267-4268	=	_
24-50	4269-4270	3	_
24-51	4271-4272	)	_
24-52	4273-4274	.	_

25-1	4275-4277	In	_
25-2	4278-4281	all	_
25-3	4282-4287	cases	_
25-4	4288-4295	alcohol	_
25-5	4296-4299	was	_
25-6	4300-4303	the	_
25-7	4304-4308	drug	_
25-8	4309-4311	of	_
25-9	4312-4318	choice	_
25-10	4319-4322	and	_
25-11	4323-4330	alcohol	_
25-12	4331-4341	dependence	_
25-13	4342-4345	was	_
25-14	4346-4350	more	_
25-15	4351-4357	recent	_
25-16	4358-4362	than	_
25-17	4363-4367	drug	_
25-18	4368-4378	dependence	_
25-19	4379-4380	.	_

26-1	4381-4384	The	_
26-2	4385-4391	median	_
26-3	4392-4399	numbers	_
26-4	4400-4402	of	_
26-5	4403-4408	years	_
26-6	4409-4414	since	_
26-7	4415-4419	last	_
26-8	4420-4423	use	_
26-9	4424-4427	was	_
26-10	4428-4430	as	_
26-11	4431-4438	follows	_
26-12	4439-4440	:	_
26-13	4441-4448	cocaine	_
26-14	4449-4450	:	_
26-15	4451-4454	1.3	_
26-16	4455-4460	years	_
26-17	4461-4462	;	_
26-18	4463-4475	amphetamines	_
26-19	4476-4477	:	_
26-20	4478-4481	6.5	_
26-21	4482-4487	years	_
26-22	4488-4489	;	_
26-23	4490-4493	and	_
26-24	4494-4501	opioids	_
26-25	4502-4503	:	_
26-26	4504-4505	2	_
26-27	4506-4511	years	_
26-28	4512-4513	.	_

27-1	4514-4521	Current	_
27-2	4522-4529	smokers	_
27-3	4530-4538	included	_
27-4	4539-4541	14	_
27-5	4542-4545	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
27-6	4546-4549	and	_
27-7	4550-4551	3	_
27-8	4552-4559	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
27-9	4560-4568	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
27-10	4569-4570	(	_
27-11	4571-4573	χ2	_
27-12	4574-4575	(	_
27-13	4576-4577	1	_
27-14	4578-4579	)	_
27-15	4580-4581	=	_
27-16	4582-4586	10.6	_
27-17	4587-4588	,	_
27-18	4589-4590	p	_
27-19	4591-4592	=	_
27-20	4593-4598	0.001	_
27-21	4599-4600	)	_
27-22	4601-4602	.	_

28-1	4603-4614	Demographic	_
28-2	4615-4619	data	_
28-3	4620-4621	,	_
28-4	4622-4629	alcohol	_
28-5	4630-4633	and	_
28-6	4634-4643	substance	_
28-7	4644-4647	use	_
28-8	4648-4655	history	_
28-9	4656-4657	,	_
28-10	4658-4662	mood	_
28-11	4663-4664	,	_
28-12	4665-4668	and	_
28-13	4669-4678	premorbid	_
28-14	4679-4691	intelligence	_
28-15	4692-4698	scores	_
28-16	4699-4702	are	_
28-17	4703-4705	in	_
28-18	4706-4711	Table	_
28-19	4712-4713	1	_
28-20	4714-4715	.	_

29-1	4716-4719	The	_
29-2	4720-4726	groups	_
29-3	4727-4731	were	_
29-4	4732-4739	matched	_
29-5	4740-4742	in	_
29-6	4743-4753	handedness	_
29-7	4754-4757	and	_
29-8	4758-4761	did	_
29-9	4762-4765	not	_
29-10	4766-4772	differ	_
29-11	4773-4775	in	_
29-12	4776-4782	visual	_
29-13	4783-4789	acuity	_
29-14	4790-4791	,	_
29-15	4792-4796	body	_
29-16	4797-4801	mass	_
29-17	4802-4807	index	_
29-18	4808-4809	(	_
29-19	4810-4813	BMI	_
29-20	4814-4815	)	_
29-21	4816-4817	,	_
29-22	4818-4821	and	_
29-23	4822-4835	physiological	_
29-24	4836-4844	measures	_
29-25	4845-4846	(	_
29-26	4847-4852	heart	_
29-27	4853-4857	rate	_
29-28	4858-4859	,	_
29-29	4860-4865	blood	_
29-30	4866-4874	pressure	_
29-31	4875-4876	)	_
29-32	4877-4878	.	_

30-1	4879-4887	Although	_
30-2	4888-4891	the	_
30-3	4892-4895	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
30-4	4896-4899	had	_
30-5	4900-4905	fewer	_
30-6	4906-4911	years	_
30-7	4912-4914	of	_
30-8	4915-4924	education	_
30-9	4925-4928	and	_
30-10	4929-4930	a	_
30-11	4931-4936	lower	_
30-12	4937-4950	socioeconomic	_
30-13	4951-4957	status	_
30-14	4958-4959	(	_
30-15	4960-4963	SES	_
30-16	4964-4965	)	_
30-17	4966-4970	than	_
30-18	4971-4979	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
30-19	4980-4981	,	_
30-20	4982-4986	both	_
30-21	4987-4993	groups	_
30-22	4994-4997	had	_
30-23	4998-5006	received	_
30-24	5007-5009	an	_
30-25	5010-5017	average	_
30-26	5018-5027	education	_
30-27	5028-5034	beyond	_
30-28	5035-5039	high	_
30-29	5040-5046	school	_
30-30	5047-5048	.	_

31-1	5049-5058	Procedure	_
31-2	5059-5062	The	_
31-3	5063-5068	study	_
31-4	5069-5072	was	_
31-5	5073-5081	approved	_
31-6	5082-5084	by	_
31-7	5085-5088	the	_
31-8	5089-5102	Institutional	_
31-9	5103-5109	Review	_
31-10	5110-5116	Boards	_
31-11	5117-5119	at	_
31-12	5120-5123	SRI	_
31-13	5124-5137	International	_
31-14	5138-5141	and	_
31-15	5142-5150	Stanford	_
31-16	5151-5161	University	_
31-17	5162-5168	School	_
31-18	5169-5171	of	_
31-19	5172-5180	Medicine	_
31-20	5181-5182	.	_

32-1	5183-5186	All	_
32-2	5187-5199	participants	_
32-3	5200-5204	gave	_
32-4	5205-5212	written	_
32-5	5213-5221	informed	_
32-6	5222-5229	consent	_
32-7	5230-5233	for	_
32-8	5234-5239	study	_
32-9	5240-5253	participation	_
32-10	5254-5255	.	_

33-1	5256-5263	Stimuli	_
33-2	5264-5267	and	_
33-3	5268-5280	experimental	_
33-4	5281-5287	design	_
33-5	5288-5291	All	_
33-6	5292-5300	subjects	_
33-7	5301-5310	performed	_
33-8	5311-5314	the	_
33-9	5315-5316	‘	_
33-10	5317-5324	Priming	_
33-11	5325-5332	emotion	_
33-12	5333-5336	and	_
33-13	5337-5344	alcohol	_
33-14	5345-5351	Stroop	_
33-15	5352-5367	Match-to-Sample	_
33-16	5368-5369	’	_
33-17	5370-5374	task	_
33-18	5375-5381	during	_
33-19	5382-5386	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
33-20	5387-5398	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
33-21	5399-5404	using	_
33-22	5405-5406	a	_
33-23	5407-5415	clinical	_
33-24	5416-5426	whole-body	_
33-25	5427-5429	GE	_
33-26	5430-5431	3	_
33-27	5432-5433	T	_
33-28	5434-5441	scanner	_
33-29	5442-5443	.	_

34-1	5444-5451	Stimuli	_
34-2	5452-5456	were	_
34-3	5457-5466	presented	_
34-4	5467-5474	through	_
34-5	5475-5476	a	_
34-6	5477-5492	rear-projection	_
34-7	5493-5499	system	_
34-8	5500-5503	and	_
34-9	5504-5510	viewed	_
34-10	5511-5514	via	_
34-11	5515-5516	a	_
34-12	5517-5523	mirror	_
34-13	5524-5532	attached	_
34-14	5533-5535	to	_
34-15	5536-5539	the	_
34-16	5540-5544	head	_
34-17	5545-5549	coil	_
34-18	5550-5551	.	_

35-1	5552-5559	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
35-2	5560-5563	and	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
35-3	5564-5571	emotion	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
35-4	5572-5579	priming	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
35-5	5580-5581	-	_
35-6	5582-5588	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
35-7	5589-5604	match-to-sample	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
35-8	5605-5609	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
35-9	5610-5613	The	_
35-10	5614-5618	task	_
35-11	5619-5629	containing	_
35-12	5630-5635	color	_
35-13	5636-5637	,	_
35-14	5638-5642	word	_
35-15	5643-5644	,	_
35-16	5645-5648	and	_
35-17	5649-5656	picture	_
35-18	5657-5664	stimuli	_
35-19	5665-5668	was	_
35-20	5669-5678	presented	_
35-21	5679-5683	with	_
35-22	5684-5692	PsyScope	_
35-23	5693-5701	software	_
35-24	5702-5705	and	_
35-25	5706-5718	synchronized	_
35-26	5719-5723	with	_
35-27	5724-5727	the	_
35-28	5728-5731	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
35-29	5732-5743	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
35-30	5744-5747	via	_
35-31	5748-5751	the	_
35-32	5752-5756	fORP	_
35-33	5757-5763	system	_
35-34	5764-5773	interface	_
35-35	5774-5775	(	_
35-36	5776-5790	www.curdes.com	_
35-37	5791-5792	)	_
35-38	5793-5794	.	_

36-1	5795-5801	Stroop	_
36-2	5802-5817	match-to-sample	_
36-3	5818-5819	:	_
36-4	5820-5827	Similar	_
36-5	5828-5830	to	_
36-6	5831-5839	previous	_
36-7	5840-5848	versions	_
36-8	5849-5851	of	_
36-9	5852-5855	the	_
36-10	5856-5862	Stroop	_
36-11	5863-5878	Match-to-Sample	_
36-12	5879-5883	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
36-13	5884-5885	(	_
36-14	5886-5890	e.g.	_
36-15	5891-5892	,	_
36-16	5893-5894	)	_
36-17	5895-5896	,	_
36-18	5897-5905	subjects	_
36-19	5906-5910	were	_
36-20	5911-5921	instructed	_
36-21	5922-5924	to	_
36-22	5925-5930	match	_
36-23	5931-5934	the	_
36-24	5935-5940	color	_
36-25	5941-5943	of	_
36-26	5944-5945	a	_
36-27	5946-5952	sample	_
36-28	5953-5961	stimulus	_
36-29	5962-5971	displayed	_
36-30	5972-5975	for	_
36-31	5976-5979	700	_
36-32	5980-5982	ms	_
36-33	5983-5985	in	_
36-34	5986-5989	the	_
36-35	5990-5996	center	_
36-36	5997-5999	of	_
36-37	6000-6003	the	_
36-38	6004-6010	screen	_
36-39	6011-6013	to	_
36-40	6014-6017	the	_
36-41	6018-6022	font	_
36-42	6023-6028	color	_
36-43	6029-6031	of	_
36-44	6032-6033	a	_
36-45	6034-6040	Stroop	_
36-46	6041-6045	word	_
36-47	6046-6054	stimulus	_
36-48	6055-6059	that	_
36-49	6060-6068	appeared	_
36-50	6069-6072	for	_
36-51	6073-6077	1100	_
36-52	6078-6080	ms	_
36-53	6081-6091	thereafter	_
36-54	6092-6093	(	_
36-55	6094-6097	Fig	_
36-56	6098-6099	.	_

37-1	6100-6102	1a	_
37-2	6103-6104	)	_
37-3	6105-6106	.	_

38-1	6107-6110	The	_
38-2	6111-6116	color	_
38-3	6117-6124	samples	_
38-4	6125-6128	and	_
38-5	6129-6135	Stroop	_
38-6	6136-6140	word	_
38-7	6141-6147	colors	_
38-8	6148-6152	were	_
38-9	6153-6156	red	_
38-10	6157-6158	,	_
38-11	6159-6164	green	_
38-12	6165-6166	,	_
38-13	6167-6169	or	_
38-14	6170-6174	blue	_
38-15	6175-6176	.	_

39-1	6177-6180	The	_
39-2	6181-6187	Stroop	_
39-3	6188-6192	word	_
39-4	6193-6196	was	_
39-5	6197-6203	either	_
39-6	6204-6213	congruent	_
39-7	6214-6215	(	_
39-8	6216-6220	word	_
39-9	6221-6224	RED	_
39-10	6225-6232	written	_
39-11	6233-6235	in	_
39-12	6236-6239	red	_
39-13	6240-6244	font	_
39-14	6245-6246	)	_
39-15	6247-6249	or	_
39-16	6250-6261	incongruent	_
39-17	6262-6263	(	_
39-18	6264-6268	word	_
39-19	6269-6272	RED	_
39-20	6273-6280	written	_
39-21	6281-6283	in	_
39-22	6284-6288	blue	_
39-23	6289-6293	font	_
39-24	6294-6295	)	_
39-25	6296-6297	.	_

40-1	6298-6301	The	_
40-2	6302-6306	font	_
40-3	6307-6312	color	_
40-4	6313-6315	of	_
40-5	6316-6319	the	_
40-6	6320-6326	Stroop	_
40-7	6327-6331	word	_
40-8	6332-6338	either	_
40-9	6339-6346	matched	_
40-10	6347-6349	or	_
40-11	6350-6353	did	_
40-12	6354-6357	not	_
40-13	6358-6363	match	_
40-14	6364-6367	the	_
40-15	6368-6374	sample	_
40-16	6375-6380	color	_
40-17	6381-6382	.	_

41-1	6383-6386	For	_
41-2	6387-6392	color	_
41-3	6393-6400	matches	_
41-4	6401-6402	,	_
41-5	6403-6411	subjects	_
41-6	6412-6419	pressed	_
41-7	6420-6421	a	_
41-8	6422-6429	YES-key	_
41-9	6430-6433	and	_
41-10	6434-6437	for	_
41-11	6438-6447	non-color	_
41-12	6448-6455	matches	_
41-13	6456-6457	,	_
41-14	6458-6459	a	_
41-15	6460-6466	NO-key	_
41-16	6467-6472	using	_
41-17	6473-6478	their	_
41-18	6479-6487	dominant	_
41-19	6488-6492	hand	_
41-20	6493-6494	,	_
41-21	6495-6502	thereby	_
41-22	6503-6512	providing	_
41-23	6513-6521	measures	_
41-24	6522-6524	of	_
41-25	6525-6533	reaction	_
41-26	6534-6538	time	_
41-27	6539-6542	and	_
41-28	6543-6551	accuracy	_
41-29	6552-6555	for	_
41-30	6556-6560	each	_
41-31	6561-6566	trial	_
41-32	6567-6568	.	_

42-1	6569-6572	For	_
42-2	6573-6593	incongruent-nonmatch	_
42-3	6594-6606	color-Stroop	_
42-4	6607-6617	conditions	_
42-5	6618-6619	,	_
42-6	6620-6623	the	_
42-7	6624-6630	sample	_
42-8	6631-6636	color	_
42-9	6637-6643	always	_
42-10	6644-6651	matched	_
42-11	6652-6655	the	_
42-12	6656-6660	word	_
42-13	6661-6668	content	_
42-14	6669-6670	(	_
42-15	6671-6675	e.g.	_
42-16	6676-6677	,	_
42-17	6678-6682	blue	_
42-18	6683-6689	sample	_
42-19	6690-6691	,	_
42-20	6692-6696	word	_
42-21	6697-6701	BLUE	_
42-22	6702-6709	written	_
42-23	6710-6712	in	_
42-24	6713-6716	red	_
42-25	6717-6721	font	_
42-26	6722-6727	color	_
42-27	6728-6729	)	_
42-28	6730-6731	.	_

43-1	6732-6734	In	_
43-2	6735-6743	contrast	_
43-3	6744-6746	to	_
43-4	6747-6755	previous	_
43-5	6756-6760	task	_
43-6	6761-6769	versions	_
43-7	6770-6771	,	_
43-8	6772-6773	a	_
43-9	6774-6781	picture	_
43-10	6782-6784	of	_
43-11	6785-6787	an	_
43-12	6788-6797	alcoholic	_
43-13	6798-6806	beverage	_
43-14	6807-6808	,	_
43-15	6809-6811	an	_
43-16	6812-6821	emotional	_
43-17	6822-6826	face	_
43-18	6827-6828	(	_
43-19	6829-6834	angry	_
43-20	6835-6836	,	_
43-21	6837-6842	happy	_
43-22	6843-6844	)	_
43-23	6845-6846	(	_
43-24	6847-6855	MacBrain	_
43-25	6856-6860	Face	_
43-26	6861-6869	Stimulus	_
43-27	6870-6873	Set	_
43-28	6874-6875	;	_
43-29	6876-6906	www.macbrain.org/resources.htm	_
43-30	6907-6908	)	_
43-31	6909-6910	,	_
43-32	6911-6913	or	_
43-33	6914-6921	neutral	_
43-34	6922-6926	gray	_
43-35	6927-6932	patch	_
43-36	6933-6936	was	_
43-37	6937-6946	presented	_
43-38	6947-6950	for	_
43-39	6951-6954	700	_
43-40	6955-6957	ms	_
43-41	6958-6965	between	_
43-42	6966-6969	the	_
43-43	6970-6975	color	_
43-44	6976-6982	sample	_
43-45	6983-6986	and	_
43-46	6987-6990	the	_
43-47	6991-6997	Stroop	_
43-48	6998-7002	word	_
43-49	7003-7004	(	_
43-50	7005-7008	Fig	_
43-51	7009-7010	.	_

44-1	7011-7012	1	_
44-2	7013-7014	)	_
44-3	7015-7016	.	_

45-1	7017-7021	This	_
45-2	7022-7026	task	_
45-3	7027-7030	was	_
45-4	7031-7039	designed	_
45-5	7040-7042	to	_
45-6	7043-7048	study	_
45-7	7049-7052	cue	_
45-8	7053-7063	reactivity	_
45-9	7064-7065	(	_
45-10	7066-7069	Fig	_
45-11	7070-7071	.	_

46-1	7072-7074	1b	_
46-2	7075-7076	)	_
46-3	7077-7080	and	_
46-4	7081-7088	priming	_
46-5	7089-7091	of	_
46-6	7092-7094	an	_
46-7	7095-7103	upcoming	_
46-8	7104-7111	emotion	_
46-9	7112-7115	and	_
46-10	7116-7131	alcohol-related	_
46-11	7132-7140	conflict	_
46-12	7141-7142	(	_
46-13	7143-7146	Fig	_
46-14	7147-7148	.	_

47-1	7149-7151	1c	_
47-2	7152-7153	)	_
47-3	7154-7156	by	_
47-4	7157-7162	using	_
47-5	7163-7171	pictures	_
47-6	7172-7176	that	_
47-7	7177-7184	validly	_
47-8	7185-7194	predicted	_
47-9	7195-7198	the	_
47-10	7199-7203	word	_
47-11	7204-7205	’	_
47-12	7206-7207	s	_
47-13	7208-7215	content	_
47-14	7216-7219	and	_
47-15	7220-7222	to	_
47-16	7223-7231	identify	_
47-17	7232-7242	processing	_
47-18	7243-7254	differences	_
47-19	7255-7262	between	_
47-20	7263-7266	ALC	_
47-21	7267-7270	and	_
47-22	7271-7279	controls	_
47-23	7280-7281	.	_

48-1	7282-7285	Cue	_
48-2	7286-7296	reactivity	_
48-3	7297-7298	:	_
48-4	7299-7301	To	_
48-5	7302-7306	test	_
48-6	7307-7310	cue	_
48-7	7311-7321	reactivity	_
48-8	7322-7324	to	_
48-9	7325-7334	emotional	_
48-10	7335-7339	face	_
48-11	7340-7343	and	_
48-12	7344-7351	alcohol	_
48-13	7352-7360	beverage	_
48-14	7361-7368	picture	_
48-15	7369-7375	trials	_
48-16	7376-7377	(	_
48-17	7378-7381	vs.	_
48-18	7382-7389	neutral	_
48-19	7390-7396	trials	_
48-20	7397-7398	)	_
48-21	7399-7400	,	_
48-22	7401-7410	congruent	_
48-23	7411-7426	non-conflicting	_
48-24	7427-7433	Stroop	_
48-25	7434-7439	words	_
48-26	7440-7444	were	_
48-27	7445-7449	used	_
48-28	7450-7451	(	_
48-29	7452-7455	Fig	_
48-30	7456-7457	.	_

49-1	7458-7460	1b	_
49-2	7461-7462	)	_
49-3	7463-7464	.	_

50-1	7465-7472	Priming	_
50-2	7473-7479	Stroop	_
50-3	7480-7481	:	_
50-4	7482-7484	To	_
50-5	7485-7489	test	_
50-6	7490-7493	the	_
50-7	7494-7500	effect	_
50-8	7501-7503	of	_
50-9	7504-7511	priming	_
50-10	7512-7519	emotion	_
50-11	7520-7523	and	_
50-12	7524-7539	alcohol-related	_
50-13	7540-7548	conflict	_
50-14	7549-7550	,	_
50-15	7551-7557	Stroop	_
50-16	7558-7563	words	_
50-17	7564-7567	had	_
50-18	7568-7570	an	_
50-19	7571-7578	alcohol	_
50-20	7579-7580	(	_
50-21	7581-7585	e.g.	_
50-22	7586-7587	,	_
50-23	7588-7592	BEER	_
50-24	7593-7594	,	_
50-25	7595-7599	WINE	_
50-26	7600-7601	,	_
50-27	7602-7609	WHISKEY	_
50-28	7610-7611	)	_
50-29	7612-7613	,	_
50-30	7614-7625	emotionally	_
50-31	7626-7634	positive	_
50-32	7635-7636	(	_
50-33	7637-7641	e.g.	_
50-34	7642-7643	,	_
50-35	7644-7649	HAPPY	_
50-36	7650-7651	,	_
50-37	7652-7655	JOY	_
50-38	7656-7657	,	_
50-39	7658-7662	GLAD	_
50-40	7663-7664	)	_
50-41	7665-7666	,	_
50-42	7667-7669	or	_
50-43	7670-7678	negative	_
50-44	7679-7686	content	_
50-45	7687-7688	(	_
50-46	7689-7693	e.g.	_
50-47	7694-7695	,	_
50-48	7696-7701	ANGRY	_
50-49	7702-7703	,	_
50-50	7704-7707	MAD	_
50-51	7708-7709	,	_
50-52	7710-7717	FURIOUS	_
50-53	7718-7719	)	_
50-54	7720-7721	;	_
50-55	7722-7726	each	_
50-56	7727-7731	word	_
50-57	7732-7735	was	_
50-58	7736-7743	printed	_
50-59	7744-7746	in	_
50-60	7747-7750	red	_
50-61	7751-7752	,	_
50-62	7753-7757	blue	_
50-63	7758-7759	,	_
50-64	7760-7762	or	_
50-65	7763-7768	green	_
50-66	7769-7773	font	_
50-67	7774-7779	color	_
50-68	7780-7781	(	_
50-69	7782-7785	Fig	_
50-70	7786-7787	.	_

51-1	7788-7789	1	_
51-2	7790-7791	)	_
51-3	7792-7793	.	_

52-1	7794-7797	The	_
52-2	7798-7805	content	_
52-3	7806-7808	of	_
52-4	7809-7812	the	_
52-5	7813-7820	picture	_
52-6	7821-7827	always	_
52-7	7828-7834	primed	_
52-8	7835-7838	the	_
52-9	7839-7846	content	_
52-10	7847-7849	of	_
52-11	7850-7853	the	_
52-12	7854-7860	Stroop	_
52-13	7861-7865	word	_
52-14	7866-7867	,	_
52-15	7868-7872	e.g.	_
52-16	7873-7874	,	_
52-17	7875-7877	an	_
52-18	7878-7883	angry	_
52-19	7884-7888	face	_
52-20	7889-7897	preceded	_
52-21	7898-7901	the	_
52-22	7902-7906	word	_
52-23	7907-7912	ANGRY	_
52-24	7913-7916	and	_
52-25	7917-7918	a	_
52-26	7919-7926	picture	_
52-27	7927-7929	of	_
52-28	7930-7931	a	_
52-29	7932-7937	glass	_
52-30	7938-7940	of	_
52-31	7941-7945	wine	_
52-32	7946-7954	preceded	_
52-33	7955-7958	the	_
52-34	7959-7963	word	_
52-35	7964-7968	WINE	_
52-36	7969-7970	.	_

53-1	7971-7974	The	_
53-2	7975-7979	task	_
53-3	7980-7983	was	_
53-4	7984-7986	to	_
53-5	7987-7988	“	_
53-6	7989-7994	match	_
53-7	7995-8001	colors	_
53-8	8002-8003	”	_
53-9	8004-8007	and	_
53-10	8008-8009	,	_
53-11	8010-8022	consequently	_
53-12	8023-8024	,	_
53-13	8025-8028	the	_
53-14	8029-8036	picture	_
53-15	8037-8042	prime	_
53-16	8043-8046	and	_
53-17	8047-8053	Stroop	_
53-18	8054-8058	word	_
53-19	8059-8066	content	_
53-20	8067-8071	were	_
53-21	8072-8075	not	_
53-22	8076-8084	relevant	_
53-23	8085-8088	for	_
53-24	8089-8097	accurate	_
53-25	8098-8109	performance	_
53-26	8110-8111	.	_

54-1	8112-8115	The	_
54-2	8116-8122	Stroop	_
54-3	8123-8127	word	_
54-4	8128-8129	’	_
54-5	8130-8131	s	_
54-6	8132-8139	content	_
54-7	8140-8141	(	_
54-8	8142-8153	incongruent	_
54-9	8154-8159	color	_
54-10	8160-8161	:	_
54-11	8162-8163	;	_
54-12	8164-8171	emotion	_
54-13	8172-8173	:	_
54-14	8174-8175	;	_
54-15	8176-8190	reward-related	_
54-16	8191-8192	:	_
54-17	8193-8194	)	_
54-18	8195-8197	is	_
54-19	8198-8205	assumed	_
54-20	8206-8208	to	_
54-21	8209-8211	be	_
54-22	8212-8221	processed	_
54-23	8222-8235	automatically	_
54-24	8236-8239	and	_
54-25	8240-8242	to	_
54-26	8243-8249	elicit	_
54-27	8250-8259	prepotent	_
54-28	8260-8269	responses	_
54-29	8270-8274	that	_
54-30	8275-8279	need	_
54-31	8280-8282	to	_
54-32	8283-8285	be	_
54-33	8286-8295	inhibited	_
54-34	8296-8298	to	_
54-35	8299-8308	correctly	_
54-36	8309-8312	and	_
54-37	8313-8324	efficiently	_
54-38	8325-8332	perform	_
54-39	8333-8336	the	_
54-40	8337-8351	color-matching	_
54-41	8352-8356	task	_
54-42	8357-8358	.	_

55-1	8359-8370	Accordingly	_
55-2	8371-8372	,	_
55-3	8373-8379	Stroop	_
55-4	8380-8387	effects	_
55-5	8388-8390	to	_
55-6	8391-8397	primed	_
55-7	8398-8405	alcohol	_
55-8	8406-8409	and	_
55-9	8410-8417	emotion	_
55-10	8418-8424	Stroop	_
55-11	8425-8435	conditions	_
55-12	8436-8439	are	_
55-13	8440-8455	operationalized	_
55-14	8456-8458	to	_
55-15	8459-8463	test	_
55-16	8464-8465	‘	_
55-17	8466-8473	current	_
55-18	8474-8478	need	_
55-19	8479-8481	or	_
55-20	8482-8487	state	_
55-21	8488-8489	,	_
55-22	8490-8491	’	_
55-23	8492-8494	in	_
55-24	8495-8498	ALC	_
55-25	8499-8507	relative	_
55-26	8508-8510	to	_
55-27	8511-8519	controls	_
55-28	8520-8521	,	_
55-29	8522-8525	and	_
55-30	8526-8528	to	_
55-31	8529-8534	weigh	_
55-32	8535-8542	against	_
55-33	8543-8553	conditions	_
55-34	8554-8556	of	_
55-35	8557-8558	‘	_
55-36	8559-8566	neutral	_
55-37	8567-8572	state	_
55-38	8573-8574	’	_
55-39	8575-8576	(	_
55-40	8577-8582	color	_
55-41	8583-8584	)	_
55-42	8585-8595	conditions	_
55-43	8596-8597	.	_

56-1	8598-8600	At	_
56-2	8601-8604	the	_
56-3	8605-8615	behavioral	_
56-4	8616-8621	level	_
56-5	8622-8623	,	_
56-6	8624-8627	the	_
56-7	8628-8634	Stroop	_
56-8	8635-8641	effect	_
56-9	8642-8643	(	_
56-10	8644-8656	interference	_
56-11	8657-8661	from	_
56-12	8662-8665	the	_
56-13	8666-8672	Stroop	_
56-14	8673-8677	word	_
56-15	8678-8679	’	_
56-16	8680-8681	s	_
56-17	8682-8689	content	_
56-18	8690-8691	)	_
56-19	8692-8694	is	_
56-20	8695-8702	defined	_
56-21	8703-8705	as	_
56-22	8706-8709	the	_
56-23	8710-8720	difference	_
56-24	8721-8723	in	_
56-25	8724-8732	reaction	_
56-26	8733-8737	time	_
56-27	8738-8739	(	_
56-28	8740-8742	RT	_
56-29	8743-8744	)	_
56-30	8745-8747	to	_
56-31	8748-8759	incongruent	_
56-32	8760-8763	and	_
56-33	8764-8773	congruent	_
56-34	8774-8784	color-word	_
56-35	8785-8792	stimuli	_
56-36	8793-8794	(	_
56-37	8795-8798	Fig	_
56-38	8799-8800	.	_

57-1	8801-8803	1a	_
57-2	8804-8805	)	_
57-3	8806-8807	.	_

58-1	8808-8817	Similarly	_
58-2	8818-8819	,	_
58-3	8820-8827	alcohol	_
58-4	8828-8831	and	_
58-5	8832-8839	emotion	_
58-6	8840-8846	Stroop	_
58-7	8847-8854	effects	_
58-8	8855-8859	were	_
58-9	8860-8867	defined	_
58-10	8868-8870	as	_
58-11	8871-8874	the	_
58-12	8875-8885	difference	_
58-13	8886-8888	in	_
58-14	8889-8891	RT	_
58-15	8892-8899	between	_
58-16	8900-8915	alcohol/emotion	_
58-17	8916-8921	words	_
58-18	8922-8925	and	_
58-19	8926-8935	congruent	_
58-20	8936-8946	color-word	_
58-21	8947-8954	stimuli	_
58-22	8955-8956	(	_
58-23	8957-8960	Fig	_
58-24	8961-8962	.	_

59-1	8963-8965	1c	_
59-2	8966-8967	)	_
59-3	8968-8969	,	_
59-4	8970-8980	equivalent	_
59-5	8981-8983	to	_
59-6	8984-8992	previous	_
59-7	8993-9000	reports	_
59-8	9001-9002	.	_

60-1	9003-9005	As	_
60-2	9006-9008	in	_
60-3	9009-9017	previous	_
60-4	9018-9022	task	_
60-5	9023-9031	versions	_
60-6	9032-9033	,	_
60-7	9034-9040	trials	_
60-8	9041-9045	were	_
60-9	9046-9055	presented	_
60-10	9056-9058	in	_
60-11	9059-9062	two	_
60-12	9063-9068	block	_
60-13	9069-9074	types	_
60-14	9075-9076	:	_
60-15	9077-9085	response	_
60-16	9086-9096	repetition	_
60-17	9097-9098	(	_
60-18	9099-9101	RR	_
60-19	9102-9103	)	_
60-20	9104-9107	and	_
60-21	9108-9116	response	_
60-22	9117-9126	switching	_
60-23	9127-9128	(	_
60-24	9129-9131	RS	_
60-25	9132-9133	)	_
60-26	9134-9140	blocks	_
60-27	9141-9142	.	_

61-1	9143-9145	RR	_
61-2	9146-9149	and	_
61-3	9150-9152	RS	_
61-4	9153-9159	blocks	_
61-5	9160-9169	comprised	_
61-6	9170-9173	the	_
61-7	9174-9178	same	_
61-8	9179-9181	96	_
61-9	9182-9187	match	_
61-10	9188-9191	and	_
61-11	9192-9200	nonmatch	_
61-12	9201-9207	trials	_
61-13	9208-9209	,	_
61-14	9210-9214	only	_
61-15	9215-9217	in	_
61-16	9218-9219	a	_
61-17	9220-9229	different	_
61-18	9230-9235	order	_
61-19	9236-9237	:	_
61-20	9238-9240	In	_
61-21	9241-9243	RS	_
61-22	9244-9250	blocks	_
61-23	9251-9252	,	_
61-24	9253-9258	color	_
61-25	9259-9264	match	_
61-26	9265-9268	and	_
61-27	9269-9277	nonmatch	_
61-28	9278-9284	trials	_
61-29	9285-9289	were	_
61-30	9290-9299	presented	_
61-31	9300-9302	in	_
61-32	9303-9304	a	_
61-33	9305-9318	pseudo-random	_
61-34	9319-9324	order	_
61-35	9325-9328	and	_
61-36	9329-9337	required	_
61-37	9338-9347	switching	_
61-38	9348-9355	between	_
61-39	9356-9359	YES	_
61-40	9360-9361	(	_
61-41	9362-9375	sample-target	_
61-42	9376-9382	colors	_
61-43	9383-9388	match	_
61-44	9389-9390	)	_
61-45	9391-9394	and	_
61-46	9395-9397	NO	_
61-47	9398-9407	responses	_
61-48	9408-9409	(	_
61-49	9410-9423	sample-target	_
61-50	9424-9430	colors	_
61-51	9431-9433	do	_
61-52	9434-9437	not	_
61-53	9438-9443	match	_
61-54	9444-9445	)	_
61-55	9446-9447	;	_
61-56	9448-9450	in	_
61-57	9451-9453	RR	_
61-58	9454-9460	blocks	_
61-59	9461-9462	,	_
61-60	9463-9469	either	_
61-61	9470-9475	color	_
61-62	9476-9481	match	_
61-63	9482-9483	(	_
61-64	9484-9487	YES	_
61-65	9488-9497	responses	_
61-66	9498-9499	)	_
61-67	9500-9502	or	_
61-68	9503-9511	nonmatch	_
61-69	9512-9518	trials	_
61-70	9519-9520	(	_
61-71	9521-9523	NO	_
61-72	9524-9533	responses	_
61-73	9534-9535	)	_
61-74	9536-9540	were	_
61-75	9541-9550	presented	_
61-76	9551-9554	and	_
61-77	9555-9558	did	_
61-78	9559-9568	therefore	_
61-79	9569-9572	not	_
61-80	9573-9580	require	_
61-81	9581-9589	response	_
61-82	9590-9598	switches	_
61-83	9599-9600	.	_

62-1	9601-9605	This	_
62-2	9606-9613	allowed	_
62-3	9614-9621	testing	_
62-4	9622-9625	the	_
62-5	9626-9632	effect	_
62-6	9633-9635	of	_
62-7	9636-9646	repetitive	_
62-8	9647-9655	behavior	_
62-9	9656-9658	on	_
62-10	9659-9662	cue	_
62-11	9663-9673	reactivity	_
62-12	9674-9677	and	_
62-13	9678-9684	Stroop	_
62-14	9685-9692	effects	_
62-15	9693-9694	.	_

63-1	9695-9697	To	_
63-2	9698-9706	quantify	_
63-3	9707-9713	Stroop	_
63-4	9714-9721	effects	_
63-5	9722-9728	within	_
63-6	9729-9730	a	_
63-7	9731-9736	block	_
63-8	9737-9743	design	_
63-9	9744-9745	,	_
63-10	9746-9757	incongruent	_
63-11	9758-9761	and	_
63-12	9762-9771	congruent	_
63-13	9772-9778	trials	_
63-14	9779-9783	were	_
63-15	9784-9789	never	_
63-16	9790-9795	mixed	_
63-17	9796-9802	within	_
63-18	9803-9804	a	_
63-19	9805-9810	block	_
63-20	9811-9812	.	_

64-1	9813-9823	Consistent	_
64-2	9824-9828	with	_
64-3	9829-9832	our	_
64-4	9833-9843	experience	_
64-5	9844-9848	with	_
64-6	9849-9857	previous	_
64-7	9858-9862	task	_
64-8	9863-9871	versions	_
64-9	9872-9874	of	_
64-10	9875-9878	the	_
64-11	9879-9885	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
64-12	9886-9901	Match-to-Sample	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
64-13	9902-9906	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
64-14	9907-9908	,	_
64-15	9909-9917	subjects	_
64-16	9918-9922	were	_
64-17	9923-9926	not	_
64-18	9927-9932	aware	_
64-19	9933-9938	about	_
64-20	9939-9942	the	_
64-21	9943-9950	blocked	_
64-22	9951-9956	trial	_
64-23	9957-9963	design	_
64-24	9964-9965	,	_
64-25	9966-9968	as	_
64-26	9969-9978	indicated	_
64-27	9979-9981	in	_
64-28	9982-9991	post-scan	_
64-29	9992-10002	interviews	_
64-30	10003-10004	.	_

65-1	10005-10008	All	_
65-2	10009-10014	study	_
65-3	10015-10027	participants	_
65-4	10028-10037	underwent	_
65-5	10038-10041	two	_
65-6	10042-10046	runs	_
65-7	10047-10049	of	_
65-8	10050-10053	the	_
65-9	10054-10069	alcohol-emotion	http://maven.renci.org/NeuroBridge/neurobridge#PennEmotionRecognitionTask
65-10	10070-10077	priming	http://maven.renci.org/NeuroBridge/neurobridge#PennEmotionRecognitionTask
65-11	10078-10084	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#PennEmotionRecognitionTask
65-12	10085-10100	match-to-sample	http://maven.renci.org/NeuroBridge/neurobridge#PennEmotionRecognitionTask
65-13	10101-10105	task	http://maven.renci.org/NeuroBridge/neurobridge#PennEmotionRecognitionTask
65-14	10106-10112	within	_
65-15	10113-10116	the	_
65-16	10117-10121	same	_
65-17	10122-10126	scan	_
65-18	10127-10134	session	_
65-19	10135-10136	;	_
65-20	10137-10141	each	_
65-21	10142-10145	run	_
65-22	10146-10155	contained	_
65-23	10156-10157	6	_
65-24	10158-10169	stimulation	_
65-25	10170-10176	blocks	_
65-26	10177-10180	for	_
65-27	10181-10185	each	_
65-28	10186-10195	condition	_
65-29	10196-10197	:	_
65-30	10198-10205	alcohol	_
65-31	10206-10207	,	_
65-32	10208-10216	positive	_
65-33	10217-10220	and	_
65-34	10221-10229	negative	_
65-35	10230-10237	emotion	_
65-36	10238-10239	,	_
65-37	10240-10243	and	_
65-38	10244-10249	color	_
65-39	10250-10251	(	_
65-40	10252-10257	block	_
65-41	10258-10259	=	_
65-42	10260-10264	8TRs	_
65-43	10265-10266	;	_
65-44	10267-10269	TR	_
65-45	10270-10271	=	_
65-46	10272-10275	2.2	_
65-47	10276-10277	s	_
65-48	10278-10279	)	_
65-49	10280-10281	.	_

66-1	10282-10287	Total	_
66-2	10288-10294	number	_
66-3	10295-10297	of	_
66-4	10298-10304	trials	_
66-5	10305-10308	was	_
66-6	10309-10312	192	_
66-7	10313-10314	.	_

67-1	10315-10318	All	_
67-2	10319-10327	subjects	_
67-3	10328-10337	performed	_
67-4	10338-10339	a	_
67-5	10340-10348	practice	_
67-6	10349-10356	session	_
67-7	10357-10363	before	_
67-8	10364-10372	entering	_
67-9	10373-10376	the	_
67-10	10377-10384	scanner	_
67-11	10385-10386	,	_
67-12	10387-10390	and	_
67-13	10391-10395	test	_
67-14	10396-10408	instructions	_
67-15	10409-10413	were	_
67-16	10414-10422	reviewed	_
67-17	10423-10430	through	_
67-18	10431-10434	the	_
67-19	10435-10442	scanner	_
67-20	10443-10444	’	_
67-21	10445-10446	s	_
67-22	10447-10455	intercom	_
67-23	10456-10462	system	_
67-24	10463-10469	before	_
67-25	10470-10474	each	_
67-26	10475-10478	run	_
67-27	10479-10480	.	_

68-1	10481-10489	Magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-2	10490-10499	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-3	10500-10507	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-4	10508-10509	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-5	10510-10513	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-6	10514-10515	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
68-7	10516-10520	Data	_
68-8	10521-10532	acquisition	_
68-9	10533-10536	and	_
68-10	10537-10545	analyses	_
68-11	10546-10553	Subject	_
68-12	10554-10560	motion	_
68-13	10561-10564	was	_
68-14	10565-10574	minimized	_
68-15	10575-10577	by	_
68-16	10578-10587	following	_
68-17	10588-10596	standard	_
68-18	10597-10606	practices	_
68-19	10607-10610	for	_
68-20	10611-10615	head	_
68-21	10616-10624	fixation	_
68-22	10625-10626	,	_
68-23	10627-10631	such	_
68-24	10632-10634	as	_
68-25	10635-10645	additional	_
68-26	10646-10653	padding	_
68-27	10654-10656	of	_
68-28	10657-10660	the	_
68-29	10661-10665	neck	_
68-30	10666-10669	and	_
68-31	10670-10673	the	_
68-32	10674-10679	sides	_
68-33	10680-10682	of	_
68-34	10683-10686	the	_
68-35	10687-10691	head	_
68-36	10692-10695	and	_
68-37	10696-10699	use	_
68-38	10700-10702	of	_
68-39	10703-10704	a	_
68-40	10705-10709	head	_
68-41	10710-10715	strap	_
68-42	10716-10717	.	_

69-1	10718-10729	Whole-brain	_
69-2	10730-10734	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
69-3	10735-10739	data	_
69-4	10740-10744	were	_
69-5	10745-10753	acquired	_
69-6	10754-10758	with	_
69-7	10759-10760	a	_
69-8	10761-10763	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
69-9	10764-10765	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
69-10	10766-10775	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
69-11	10776-10784	gradient	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
69-12	10785-10796	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
69-13	10797-10802	pulse	_
69-14	10803-10811	sequence	_
69-15	10812-10813	(	_
69-16	10814-10816	2D	_
69-17	10817-10822	axial	_
69-18	10823-10824	,	_
69-19	10825-10827	TE	_
69-20	10828-10829	=	_
69-21	10830-10832	30	_
69-22	10833-10835	ms	_
69-23	10836-10837	;	_
69-24	10838-10840	TR	_
69-25	10841-10842	=	_
69-26	10843-10847	2200	_
69-27	10848-10850	ms	_
69-28	10851-10852	;	_
69-29	10853-10857	flip	_
69-30	10858-10863	angle	_
69-31	10864-10865	=	_
69-32	10866-10869	90°	_
69-33	10870-10871	;	_
69-34	10872-10874	in	_
69-35	10875-10880	plane	_
69-36	10881-10891	resolution	_
69-37	10892-10893	=	_
69-38	10894-10898	3.75	_
69-39	10899-10900	×	_
69-40	10901-10908	3.75mm2	_
69-41	10909-10910	;	_
69-42	10911-10916	thick	_
69-43	10917-10918	=	_
69-44	10919-10920	5	_
69-45	10921-10923	mm	_
69-46	10924-10925	;	_
69-47	10926-10929	gap	_
69-48	10930-10931	=	_
69-49	10932-10933	0	_
69-50	10934-10936	mm	_
69-51	10937-10938	;	_
69-52	10939-10945	number	_
69-53	10946-10948	of	_
69-54	10949-10955	slices	_
69-55	10956-10957	=	_
69-56	10958-10960	36	_
69-57	10961-10962	;	_
69-58	10963-10966	FOV	_
69-59	10967-10968	=	_
69-60	10969-10979	240×240mm2	_
69-61	10980-10981	;	_
69-62	10982-10983	1	_
69-63	10984-10987	NEX	_
69-64	10988-10989	)	_
69-65	10990-10991	.	_

70-1	10992-10993	A	_
70-2	10994-11003	dual-echo	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-3	11004-11008	fast	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-4	11009-11013	spin	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-5	11014-11018	echo	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-6	11019-11020	(	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-7	11021-11024	FSE	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-8	11025-11026	)	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-9	11027-11031	scan	http://maven.renci.org/NeuroBridge/neurobridge#EpworthSleepinessScale
70-10	11032-11035	was	_
70-11	11036-11044	acquired	_
70-12	11045-11046	(	_
70-13	11047-11049	2D	_
70-14	11050-11055	axial	_
70-15	11056-11057	;	_
70-16	11058-11060	TR	_
70-17	11061-11062	=	_
70-18	11063-11067	5000	_
70-19	11068-11070	ms	_
70-20	11071-11072	;	_
70-21	11073-11075	TE	_
70-22	11076-11077	=	_
70-23	11078-11084	17/102	_
70-24	11085-11087	ms	_
70-25	11088-11089	;	_
70-26	11090-11095	thick	_
70-27	11096-11097	=	_
70-28	11098-11099	5	_
70-29	11100-11102	mm	_
70-30	11103-11104	;	_
70-31	11105-11108	gap	_
70-32	11109-11110	=	_
70-33	11111-11112	0	_
70-34	11113-11115	mm	_
70-35	11116-11117	;	_
70-36	11118-11120	xy	_
70-37	11121-11127	matrix	_
70-38	11128-11129	=	_
70-39	11130-11133	256	_
70-40	11134-11135	×	_
70-41	11136-11139	256	_
70-42	11140-11141	;	_
70-43	11142-11146	flip	_
70-44	11147-11152	angle	_
70-45	11153-11154	=	_
70-46	11155-11158	90°	_
70-47	11159-11160	;	_
70-48	11161-11167	number	_
70-49	11168-11170	of	_
70-50	11171-11177	slices	_
70-51	11178-11179	=	_
70-52	11180-11182	36	_
70-53	11183-11184	;	_
70-54	11185-11188	FOV	_
70-55	11189-11190	=	_
70-56	11191-11201	240×240mm2	_
70-57	11202-11203	;	_
70-58	11204-11205	1	_
70-59	11206-11209	NEX	_
70-60	11210-11211	)	_
70-61	11212-11215	and	_
70-62	11216-11220	used	_
70-63	11221-11224	for	_
70-64	11225-11234	spatially	_
70-65	11235-11246	registering	_
70-66	11247-11250	the	_
70-67	11251-11255	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
70-68	11256-11260	data	_
70-69	11261-11262	.	_

71-1	11263-11268	Image	_
71-2	11269-11282	preprocessing	_
71-3	11283-11286	and	_
71-4	11287-11298	statistical	_
71-5	11299-11307	analyses	_
71-6	11308-11311	The	_
71-7	11312-11316	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
71-8	11317-11325	analysis	_
71-9	11326-11329	was	_
71-10	11330-11334	done	_
71-11	11335-11339	with	_
71-12	11340-11343	the	_
71-13	11344-11348	SPM8	_
71-14	11349-11357	software	_
71-15	11358-11365	package	_
71-16	11366-11367	(	_
71-17	11368-11376	Wellcome	_
71-18	11377-11387	Department	_
71-19	11388-11390	of	_
71-20	11391-11400	Cognitive	_
71-21	11401-11410	Neurology	_
71-22	11411-11412	,	_
71-23	11413-11415	UK	_
71-24	11416-11417	;	_
71-25	11418-11422	http	_
71-26	11423-11424	:	_
71-27	11425-11453	//www.fil.ion.ucl.ac.uk/spm/	_
71-28	11454-11455	)	_
71-29	11456-11459	and	_
71-30	11460-11467	focused	_
71-31	11468-11470	on	_
71-32	11471-11474	the	_
71-33	11475-11480	whole	_
71-34	11481-11486	brain	_
71-35	11487-11488	.	_

72-1	11489-11492	The	_
72-2	11493-11503	functional	_
72-3	11504-11510	images	_
72-4	11511-11515	were	_
72-5	11516-11525	subjected	_
72-6	11526-11528	to	_
72-7	11529-11538	geometric	_
72-8	11539-11549	distortion	_
72-9	11550-11551	(	_
72-10	11552-11557	field	_
72-11	11558-11561	map	_
72-12	11562-11563	)	_
72-13	11564-11574	correction	_
72-14	11575-11578	and	_
72-15	11579-11582	the	_
72-16	11583-11594	time-series	_
72-17	11595-11599	were	_
72-18	11600-11609	realigned	_
72-19	11610-11612	to	_
72-20	11613-11616	the	_
72-21	11617-11622	first	_
72-22	11623-11628	image	_
72-23	11629-11631	as	_
72-24	11632-11641	reference	_
72-25	11642-11647	image	_
72-26	11648-11650	to	_
72-27	11651-11657	remove	_
72-28	11658-11666	movement	_
72-29	11667-11676	artifacts	_
72-30	11677-11679	in	_
72-31	11680-11684	fMRI	_
72-32	11685-11686	.	_

73-1	11687-11690	The	_
73-2	11691-11694	FSE	http://maven.renci.org/NeuroBridge/neurobridge#Thing
73-3	11695-11705	structural	_
73-4	11706-11712	images	_
73-5	11713-11717	were	_
73-6	11718-11731	co-registered	_
73-7	11732-11734	to	_
73-8	11735-11738	the	_
73-9	11739-11743	mean	_
73-10	11744-11752	unwarped	_
73-11	11753-11756	and	_
73-12	11757-11773	motion-corrected	_
73-13	11774-11784	functional	_
73-14	11785-11790	image	_
73-15	11791-11794	for	_
73-16	11795-11799	each	_
73-17	11800-11807	subject	_
73-18	11808-11811	and	_
73-19	11812-11821	segmented	_
73-20	11822-11826	into	_
73-21	11827-11831	gray	_
73-22	11832-11835	and	_
73-23	11836-11841	white	_
73-24	11842-11848	matter	_
73-25	11849-11855	images	_
73-26	11856-11857	.	_

74-1	11858-11868	Functional	_
74-2	11869-11872	and	_
74-3	11873-11883	structural	_
74-4	11884-11888	gray	_
74-5	11889-11895	matter	_
74-6	11896-11902	images	_
74-7	11903-11907	were	_
74-8	11908-11918	normalized	_
74-9	11919-11921	to	_
74-10	11922-11930	Montreal	_
74-11	11931-11943	Neurological	_
74-12	11944-11953	Institute	_
74-13	11954-11955	(	_
74-14	11956-11959	MNI	_
74-15	11960-11961	)	_
74-16	11962-11967	space	_
74-17	11968-11976	assuring	_
74-18	11977-11981	that	_
74-19	11982-11985	the	_
74-20	11986-11990	fMRI	_
74-21	11991-11997	signal	_
74-22	11998-12001	was	_
74-23	12002-12010	confined	_
74-24	12011-12013	to	_
74-25	12014-12018	gray	_
74-26	12019-12025	matter	_
74-27	12026-12027	.	_

75-1	12028-12038	Functional	_
75-2	12039-12046	volumes	_
75-3	12047-12051	were	_
75-4	12052-12060	smoothed	_
75-5	12061-12065	with	_
75-6	12066-12067	a	_
75-7	12068-12076	Gaussian	_
75-8	12077-12083	kernel	_
75-9	12084-12086	of	_
75-10	12087-12088	8	_
75-11	12089-12091	mm	_
75-12	12092-12093	(	_
75-13	12094-12098	FWHM	_
75-14	12099-12100	)	_
75-15	12101-12102	.	_

76-1	12103-12113	Individual	_
76-2	12114-12124	statistics	_
76-3	12125-12129	were	_
76-4	12130-12138	computed	_
76-5	12139-12144	using	_
76-6	12145-12146	a	_
76-7	12147-12154	general	_
76-8	12155-12161	linear	_
76-9	12162-12167	model	_
76-10	12168-12169	(	_
76-11	12170-12173	GLM	_
76-12	12174-12175	)	_
76-13	12176-12184	approach	_
76-14	12185-12187	as	_
76-15	12188-12199	implemented	_
76-16	12200-12202	in	_
76-17	12203-12207	SPM8	_
76-18	12208-12211	and	_
76-19	12212-12217	using	_
76-20	12218-12221	the	_
76-21	12222-12233	realignment	_
76-22	12234-12244	parameters	_
76-23	12245-12249	from	_
76-24	12250-12254	each	_
76-25	12255-12258	run	_
76-26	12259-12261	as	_
76-27	12262-12271	confounds	_
76-28	12272-12273	.	_

77-1	12274-12285	Statistical	_
77-2	12286-12299	preprocessing	_
77-3	12300-12309	consisted	_
77-4	12310-12312	of	_
77-5	12313-12322	high-pass	_
77-6	12323-12332	filtering	_
77-7	12333-12335	at	_
77-8	12336-12340	70.4	_
77-9	12341-12342	s	_
77-10	12343-12344	,	_
77-11	12345-12353	low-pass	_
77-12	12354-12363	filtering	_
77-13	12364-12371	through	_
77-14	12372-12383	convolution	_
77-15	12384-12388	with	_
77-16	12389-12392	the	_
77-17	12393-12402	canonical	_
77-18	12403-12414	hemodynamic	_
77-19	12415-12423	response	_
77-20	12424-12432	function	_
77-21	12433-12434	,	_
77-22	12435-12438	and	_
77-23	12439-12445	global	_
77-24	12446-12453	scaling	_
77-25	12454-12455	.	_

78-1	12456-12459	For	_
78-2	12460-12465	first	_
78-3	12466-12471	level	_
78-4	12472-12480	analysis	_
78-5	12481-12482	,	_
78-6	12483-12486	one	_
78-7	12487-12492	image	_
78-8	12493-12496	per	_
78-9	12497-12505	contrast	_
78-10	12506-12509	was	_
78-11	12510-12518	computed	_
78-12	12519-12523	from	_
78-13	12524-12525	a	_
78-14	12526-12532	design	_
78-15	12533-12539	matrix	_
78-16	12540-12544	that	_
78-17	12545-12553	included	_
78-18	12554-12557	the	_
78-19	12558-12562	task	_
78-20	12563-12573	conditions	_
78-21	12574-12576	as	_
78-22	12577-12588	explanatory	_
78-23	12589-12598	variables	_
78-24	12599-12601	in	_
78-25	12602-12610	addition	_
78-26	12611-12613	to	_
78-27	12614-12617	the	_
78-28	12618-12627	estimated	_
78-29	12628-12638	individual	_
78-30	12639-12647	movement	_
78-31	12648-12658	parameters	_
78-32	12659-12661	as	_
78-33	12662-12672	regressors	_
78-34	12673-12674	.	_

79-1	12675-12678	Cue	_
79-2	12679-12689	reactivity	_
79-3	12690-12699	contrasts	_
79-4	12700-12702	of	_
79-5	12703-12711	interest	_
79-6	12712-12716	were	_
79-7	12717-12724	derived	_
79-8	12725-12727	at	_
79-9	12728-12731	the	_
79-10	12732-12742	individual	_
79-11	12743-12751	analysis	_
79-12	12752-12757	level	_
79-13	12758-12761	for	_
79-14	12762-12774	non-conflict	_
79-15	12775-12781	trials	_
79-16	12782-12783	(	_
79-17	12784-12787	Fig	_
79-18	12788-12789	.	_

80-1	12790-12792	1b	_
80-2	12793-12794	)	_
80-3	12795-12796	:	_
80-4	12797-12800	for	_
80-5	12801-12808	Alcohol	_
80-6	12809-12811	by	_
80-7	12812-12823	contrasting	_
80-8	12824-12831	alcohol	_
80-9	12832-12840	beverage	_
80-10	12841-12849	pictures	_
80-11	12850-12852	to	_
80-12	12853-12862	congruent	_
80-13	12863-12864	(	_
80-14	12865-12871	alcpic	_
80-15	12872-12873	>	_
80-16	12874-12877	con	_
80-17	12878-12879	)	_
80-18	12880-12890	conditions	_
80-19	12891-12892	,	_
80-20	12893-12896	for	_
80-21	12897-12913	Positive-Emotion	_
80-22	12914-12916	by	_
80-23	12917-12928	contrasting	_
80-24	12929-12934	happy	_
80-25	12935-12939	face	_
80-26	12940-12948	pictures	_
80-27	12949-12951	to	_
80-28	12952-12961	congruent	_
80-29	12962-12963	(	_
80-30	12964-12970	pospic	_
80-31	12971-12972	>	_
80-32	12973-12976	con	_
80-33	12977-12978	)	_
80-34	12979-12989	conditions	_
80-35	12990-12991	,	_
80-36	12992-12995	and	_
80-37	12996-12999	for	_
80-38	13000-13016	Negative-Emotion	_
80-39	13017-13019	by	_
80-40	13020-13031	contrasting	_
80-41	13032-13037	angry	_
80-42	13038-13042	face	_
80-43	13043-13051	pictures	_
80-44	13052-13054	to	_
80-45	13055-13064	congruent	_
80-46	13065-13066	(	_
80-47	13067-13073	negpic	_
80-48	13074-13075	>	_
80-49	13076-13079	con	_
80-50	13080-13081	)	_
80-51	13082-13092	conditions	_
80-52	13093-13094	.	_

81-1	13095-13102	Priming	_
81-2	13103-13109	Stroop	_
81-3	13110-13118	conflict	_
81-4	13119-13128	contrasts	_
81-5	13129-13131	of	_
81-6	13132-13140	interest	_
81-7	13141-13145	were	_
81-8	13146-13153	derived	_
81-9	13154-13157	for	_
81-10	13158-13165	alcohol	_
81-11	13166-13169	and	_
81-12	13170-13177	emotion	_
81-13	13178-13182	word	_
81-14	13183-13191	conflict	_
81-15	13192-13198	trials	_
81-16	13199-13200	(	_
81-17	13201-13204	Fig	_
81-18	13205-13206	.	_

82-1	13207-13209	1c	_
82-2	13210-13211	)	_
82-3	13212-13213	:	_
82-4	13214-13217	for	_
82-5	13218-13225	Alcohol	_
82-6	13226-13232	Stroop	_
82-7	13233-13235	by	_
82-8	13236-13247	contrasting	_
82-9	13248-13255	alcohol	_
82-10	13256-13258	to	_
82-11	13259-13268	congruent	_
82-12	13269-13270	(	_
82-13	13271-13274	alc	_
82-14	13275-13276	>	_
82-15	13277-13280	con	_
82-16	13281-13282	)	_
82-17	13283-13293	conditions	_
82-18	13294-13295	,	_
82-19	13296-13299	for	_
82-20	13300-13316	Positive-Emotion	_
82-21	13317-13323	Stroop	_
82-22	13324-13326	by	_
82-23	13327-13338	contrasting	_
82-24	13339-13347	positive	_
82-25	13348-13355	emotion	_
82-26	13356-13358	to	_
82-27	13359-13368	congruent	_
82-28	13369-13370	(	_
82-29	13371-13374	pos	_
82-30	13375-13376	>	_
82-31	13377-13380	con	_
82-32	13381-13382	)	_
82-33	13383-13393	conditions	_
82-34	13394-13395	,	_
82-35	13396-13399	and	_
82-36	13400-13403	for	_
82-37	13404-13420	Negative-Emotion	_
82-38	13421-13427	Stroop	_
82-39	13428-13430	by	_
82-40	13431-13442	contrasting	_
82-41	13443-13451	positive	_
82-42	13452-13459	emotion	_
82-43	13460-13462	to	_
82-44	13463-13472	congruent	_
82-45	13473-13474	(	_
82-46	13475-13478	neg	_
82-47	13479-13480	>	_
82-48	13481-13484	con	_
82-49	13485-13486	)	_
82-50	13487-13497	conditions	_
82-51	13498-13499	.	_

83-1	13500-13502	In	_
83-2	13503-13511	addition	_
83-3	13512-13513	,	_
83-4	13514-13524	individual	_
83-5	13525-13530	color	_
83-6	13531-13537	Stroop	_
83-7	13538-13547	contrasts	_
83-8	13548-13549	,	_
83-9	13550-13557	derived	_
83-10	13558-13560	by	_
83-11	13561-13572	contrasting	_
83-12	13573-13584	incongruent	_
83-13	13585-13587	to	_
83-14	13588-13597	congruent	_
83-15	13598-13608	color-word	_
83-16	13609-13610	(	_
83-17	13611-13614	inc	_
83-18	13615-13616	>	_
83-19	13617-13620	con	_
83-20	13621-13622	)	_
83-21	13623-13633	conditions	_
83-22	13634-13635	(	_
83-23	13636-13639	Fig	_
83-24	13640-13641	.	_

84-1	13642-13644	1a	_
84-2	13645-13646	)	_
84-3	13647-13648	,	_
84-4	13649-13653	were	_
84-5	13654-13659	added	_
84-6	13660-13662	to	_
84-7	13663-13666	the	_
84-8	13667-13672	model	_
84-9	13673-13676	for	_
84-10	13677-13687	comparison	_
84-11	13688-13689	(	_
84-12	13690-13693	see	_
84-13	13694-13698	also	_
84-14	13699-13700	)	_
84-15	13701-13702	.	_

85-1	13703-13706	The	_
85-2	13707-13717	individual	_
85-3	13718-13726	contrast	_
85-4	13727-13733	images	_
85-5	13734-13738	were	_
85-6	13739-13743	then	_
85-7	13744-13753	subjected	_
85-8	13754-13756	to	_
85-9	13757-13763	random	_
85-10	13764-13771	effects	_
85-11	13772-13780	analyses	_
85-12	13781-13784	for	_
85-13	13785-13790	group	_
85-14	13791-13800	averaging	_
85-15	13801-13804	and	_
85-16	13805-13815	population	_
85-17	13816-13825	inference	_
85-18	13826-13827	.	_

86-1	13828-13831	The	_
86-2	13832-13838	second	_
86-3	13839-13844	level	_
86-4	13845-13851	design	_
86-5	13852-13858	matrix	_
86-6	13859-13867	involved	_
86-7	13868-13871	two	_
86-8	13872-13881	factorial	_
86-9	13882-13888	models	_
86-10	13889-13890	,	_
86-11	13891-13895	each	_
86-12	13896-13900	with	_
86-13	13901-13902	2	_
86-14	13903-13910	factors	_
86-15	13911-13912	,	_
86-16	13913-13918	which	_
86-17	13919-13923	were	_
86-18	13924-13927	for	_
86-19	13928-13931	cue	_
86-20	13932-13942	reactivity	_
86-21	13943-13944	:	_
86-22	13945-13950	group	_
86-23	13951-13952	(	_
86-24	13953-13956	ALC	_
86-25	13957-13958	,	_
86-26	13959-13962	CTL	_
86-27	13963-13964	)	_
86-28	13965-13968	and	_
86-29	13969-13976	picture	_
86-30	13977-13980	cue	_
86-31	13981-13982	(	_
86-32	13983-13990	alcohol	_
86-33	13991-13999	beverage	_
86-34	14000-14001	,	_
86-35	14002-14007	happy	_
86-36	14008-14013	faces	_
86-37	14014-14015	,	_
86-38	14016-14021	angry	_
86-39	14022-14027	faces	_
86-40	14028-14029	)	_
86-41	14030-14031	,	_
86-42	14032-14035	and	_
86-43	14036-14039	for	_
86-44	14040-14047	priming	_
86-45	14048-14054	Stroop	_
86-46	14055-14056	:	_
86-47	14057-14062	group	_
86-48	14063-14064	(	_
86-49	14065-14068	ALC	_
86-50	14069-14070	,	_
86-51	14071-14074	CTL	_
86-52	14075-14076	)	_
86-53	14077-14080	and	_
86-54	14081-14087	Stroop	_
86-55	14088-14089	(	_
86-56	14090-14095	color	_
86-57	14096-14097	,	_
86-58	14098-14105	alcohol	_
86-59	14106-14107	,	_
86-60	14108-14116	positive	_
86-61	14117-14124	emotion	_
86-62	14125-14126	,	_
86-63	14127-14135	negative	_
86-64	14136-14143	emotion	_
86-65	14144-14145	)	_
86-66	14146-14147	,	_
86-67	14148-14151	and	_
86-68	14152-14157	their	_
86-69	14158-14169	interaction	_
86-70	14170-14171	.	_

87-1	14172-14177	Whole	_
87-2	14178-14183	brain	_
87-3	14184-14193	corrected	_
87-4	14194-14206	p-thresholds	_
87-5	14207-14210	for	_
87-6	14211-14219	combined	_
87-7	14220-14227	spatial	_
87-8	14228-14234	extent	_
87-9	14235-14238	and	_
87-10	14239-14243	peak	_
87-11	14244-14253	intensity	_
87-12	14254-14255	(	_
87-13	14256-14259	see	_
87-14	14260-14264	also	_
87-15	14265-14266	)	_
87-16	14267-14271	were	_
87-17	14272-14275	set	_
87-18	14276-14278	at	_
87-19	14279-14289	pcorrected	_
87-20	14290-14291	<	_
87-21	14292-14296	0.05	_
87-22	14297-14300	and	_
87-23	14301-14311	calculated	_
87-24	14312-14316	with	_
87-25	14317-14327	3dClustSim	_
87-26	14328-14329	(	_
87-27	14330-14335	https	_
87-28	14336-14337	:	_
87-29	14338-14399	//afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html	_
87-30	14400-14401	)	_
87-31	14402-14403	(	_
87-32	14404-14407	see	_
87-33	14408-14412	also	_
87-34	14413-14414	)	_
87-35	14415-14416	.	_

88-1	14417-14428	Statistical	_
88-2	14429-14437	analyses	_
88-3	14438-14442	Data	_
88-4	14443-14451	analysis	_
88-5	14452-14454	of	_
88-6	14455-14461	Stroop	_
88-7	14462-14466	task	_
88-8	14467-14478	performance	_
88-9	14479-14482	was	_
88-10	14483-14492	conducted	_
88-11	14493-14497	with	_
88-12	14498-14501	the	_
88-13	14502-14513	statistical	_
88-14	14514-14522	software	_
88-15	14523-14530	package	_
88-16	14531-14535	SPSS	_
88-17	14536-14546	Statistics	_
88-18	14547-14551	23.0	_
88-19	14552-14553	.	_

89-1	14554-14562	Repeated	_
89-2	14563-14571	measures	_
89-3	14572-14580	analysis	_
89-4	14581-14583	of	_
89-5	14584-14592	variance	_
89-6	14593-14594	(	_
89-7	14595-14600	ANOVA	_
89-8	14601-14602	)	_
89-9	14603-14609	tested	_
89-10	14610-14615	group	_
89-11	14616-14623	effects	_
89-12	14624-14625	(	_
89-13	14626-14629	ALC	_
89-14	14630-14631	,	_
89-15	14632-14640	controls	_
89-16	14641-14642	)	_
89-17	14643-14646	for	_
89-18	14647-14650	cue	_
89-19	14651-14661	reactivity	_
89-20	14662-14663	,	_
89-21	14664-14674	color-word	_
89-22	14675-14681	Stroop	_
89-23	14682-14685	and	_
89-24	14686-14692	primed	_
89-25	14693-14708	alcohol-emotion	_
89-26	14709-14715	Stroop	_
89-27	14716-14717	.	_

90-1	14718-14721	The	_
90-2	14722-14727	alpha	_
90-3	14728-14729	p	_
90-4	14730-14735	level	_
90-5	14736-14739	was	_
90-6	14740-14743	set	_
90-7	14744-14746	to	_
90-8	14747-14751	0.05	_
90-9	14752-14753	.	_

91-1	14754-14756	To	_
91-2	14757-14761	test	_
91-3	14762-14765	our	_
91-4	14766-14777	directional	_
91-5	14778-14788	hypothesis	_
91-6	14789-14790	,	_
91-7	14791-14796	where	_
91-8	14797-14798	‘	_
91-9	14799-14806	current	_
91-10	14807-14816	relevance	_
91-11	14817-14819	or	_
91-12	14820-14824	need	_
91-13	14825-14826	’	_
91-14	14827-14829	in	_
91-15	14830-14833	ALC	_
91-16	14834-14835	(	_
91-17	14836-14845	addiction	_
91-18	14846-14854	severity	_
91-19	14855-14856	,	_
91-20	14857-14864	craving	_
91-21	14865-14866	)	_
91-22	14867-14872	would	_
91-23	14873-14882	correlate	_
91-24	14883-14887	with	_
91-25	14888-14892	more	_
91-26	14893-14896	cue	_
91-27	14897-14907	reactivity	_
91-28	14908-14911	and	_
91-29	14912-14922	difficulty	_
91-30	14923-14925	in	_
91-31	14926-14935	executive	_
91-32	14936-14943	control	_
91-33	14944-14945	(	_
91-34	14946-14953	greater	_
91-35	14954-14960	Stroop	_
91-36	14961-14969	conflict	_
91-37	14970-14971	)	_
91-38	14972-14973	,	_
91-39	14974-14976	we	_
91-40	14977-14981	used	_
91-41	14982-14992	one-tailed	_
91-42	14993-15001	Spearman	_
91-43	15002-15005	Rho	_
91-44	15006-15017	correlation	_
91-45	15018-15019	(	_
91-46	15020-15024	SPSS	_
91-47	15025-15029	23.0	_
91-48	15030-15038	software	_
91-49	15039-15046	package	_
91-50	15047-15048	)	_
91-51	15049-15050	.	_

92-1	15051-15053	We	_
92-2	15054-15063	extracted	_
92-3	15064-15074	individual	_
92-4	15075-15077	MR	_
92-5	15078-15084	signal	_
92-6	15085-15091	change	_
92-7	15092-15096	from	_
92-8	15097-15108	significant	_
92-9	15109-15117	clusters	_
92-10	15118-15120	in	_
92-11	15121-15128	frontal	_
92-12	15129-15130	,	_
92-13	15131-15134	and	_
92-14	15135-15159	midbrain-limbic-striatal	_
92-15	15160-15167	regions	_
92-16	15168-15169	(	_
92-17	15170-15173	see	_
92-18	15174-15180	Tables	_
92-19	15181-15184	2–4	_
92-20	15185-15186	)	_
92-21	15187-15192	using	_
92-22	15193-15196	the	_
92-23	15197-15209	matlab-based	_
92-24	15210-15224	SPM-compatible	_
92-25	15225-15232	MarsBar	_
92-26	15233-15240	toolbox	_
92-27	15241-15242	(	_
92-28	15243-15247	http	_
92-29	15248-15249	:	_
92-30	15250-15287	//marsbar.sourceforge.net/marsbar.pdf	_
92-31	15288-15289	)	_
92-32	15290-15291	.	_

93-1	15292-15297	These	_
93-2	15298-15304	values	_
93-3	15305-15309	were	_
93-4	15310-15314	then	_
93-5	15315-15319	read	_
93-6	15320-15324	into	_
93-7	15325-15329	SPSS	_
93-8	15330-15332	to	_
93-9	15333-15337	test	_
93-10	15338-15341	our	_
93-11	15342-15350	specific	_
93-12	15351-15365	brain-behavior	_
93-13	15366-15376	hypothesis	_
93-14	15377-15381	that	_
93-15	15382-15406	midbrain-limbic-striatal	_
93-16	15407-15415	activity	_
93-17	15416-15418	to	_
93-18	15419-15430	emotion-and	_
93-19	15431-15446	alcohol-related	_
93-20	15447-15451	cues	_
93-21	15452-15457	would	_
93-22	15458-15460	be	_
93-23	15461-15471	associated	_
93-24	15472-15476	with	_
93-25	15477-15484	craving	_
93-26	15485-15494	intensity	_
93-27	15495-15497	or	_
93-28	15498-15507	addiction	_
93-29	15508-15516	severity	_
93-30	15517-15519	in	_
93-31	15520-15523	ALC	_
93-32	15524-15525	,	_
93-33	15526-15529	and	_
93-34	15530-15534	that	_
93-35	15535-15542	frontal	_
93-36	15543-15551	activity	_
93-37	15552-15557	would	_
93-38	15558-15560	be	_
93-39	15561-15571	associated	_
93-40	15572-15576	with	_
93-41	15577-15580	the	_
93-42	15581-15587	degree	_
93-43	15588-15590	of	_
93-44	15591-15603	interference	_
93-45	15604-15608	from	_
93-46	15609-15617	emotion-	_
93-47	15618-15621	and	_
93-48	15622-15637	alcohol-related	_
93-49	15638-15646	stimulus	_
93-50	15647-15654	content	_
93-51	15655-15656	,	_
93-52	15657-15661	i.e.	_
93-53	15662-15663	,	_
93-54	15664-15670	primed	_
93-55	15671-15677	Stroop	_
93-56	15678-15686	conflict	_
93-57	15687-15688	,	_
93-58	15689-15692	and	_
93-59	15693-15705	extrastriate	_
93-60	15706-15716	activation	_
93-61	15717-15721	with	_
93-62	15722-15726	less	_
93-63	15727-15733	primed	_
93-64	15734-15740	Stroop	_
93-65	15741-15749	conflict	_
93-66	15750-15751	.	_

94-1	15752-15763	Significant	_
94-2	15764-15769	voxel	_
94-3	15770-15777	cluster	_
94-4	15778-15780	of	_
94-5	15781-15791	activation	_
94-6	15792-15793	,	_
94-7	15794-15802	specific	_
94-8	15803-15805	to	_
94-9	15806-15810	each	_
94-10	15811-15819	contrast	_
94-11	15820-15821	,	_
94-12	15822-15826	were	_
94-13	15827-15837	correlated	_
94-14	15838-15842	with	_
94-15	15843-15846	the	_
94-16	15847-15857	respective	_
94-17	15858-15868	behavioral	_
94-18	15869-15875	effect	_
94-19	15876-15877	(	_
94-20	15878-15882	e.g.	_
94-21	15883-15884	,	_
94-22	15885-15888	for	_
94-23	15889-15892	cue	_
94-24	15893-15903	reactivity	_
94-25	15904-15906	or	_
94-26	15907-15913	primed	_
94-27	15914-15920	Stroop	_
94-28	15921-15928	effects	_
94-29	15929-15930	)	_
94-30	15931-15934	and	_
94-31	15935-15939	mood	_
94-32	15940-15946	scores	_
94-33	15947-15948	(	_
94-34	15949-15956	anxiety	_
94-35	15957-15958	,	_
94-36	15959-15962	BDI	_
94-37	15963-15964	)	_
94-38	15965-15966	,	_
94-39	15967-15970	and	_
94-40	15971-15973	in	_
94-41	15974-15977	ALC	_
94-42	15978-15982	with	_
94-43	15983-15990	alcohol	_
94-44	15991-15995	data	_
94-45	15996-15997	(	_
94-46	15998-16006	lifetime	_
94-47	16007-16014	alcohol	_
94-48	16015-16026	consumption	_
94-49	16027-16028	,	_
94-50	16029-16036	alcohol	_
94-51	16037-16045	severity	_
94-52	16046-16047	,	_
94-53	16048-16055	craving	_
94-54	16056-16057	)	_
94-55	16058-16059	.	_

95-1	16060-16071	Family-wise	_
95-2	16072-16082	Bonferroni	_
95-3	16083-16093	correction	_
95-4	16094-16097	for	_
95-5	16098-16099	6	_
95-6	16100-16111	comparisons	_
95-7	16112-16120	required	_
95-8	16121-16122	p	_
95-9	16123-16129	levels	_
95-10	16130-16137	between	_
95-11	16138-16139	p	_
95-12	16140-16141	≤	_
95-13	16142-16147	0.016	_
95-14	16148-16149	(	_
95-15	16150-16153	for	_
95-16	16154-16162	directed	_
95-17	16163-16173	hypothesis	_
95-18	16174-16175	,	_
95-19	16176-16184	1-tailed	_
95-20	16185-16186	)	_
95-21	16187-16190	and	_
95-22	16191-16192	p	_
95-23	16193-16194	≤	_
95-24	16195-16199	.008	_
95-25	16200-16201	(	_
95-26	16202-16210	2-tailed	_
95-27	16211-16212	)	_
95-28	16213-16214	.	_

